Skip to content
Retail trade
KZActiveBIN 211140013912
Plans from 2 000 ₸ a month
3/22
Some flags: tax arrears over 150 MCI and 2 more
Matches in 3 of 22 risk registers
To risks

ТОО "VET-APTEKA.LTD"

Director
Кохан Татьяна Игоревна
Incorporated
11.11.2021
Address
Алматы пр. РАЙЫМБЕКА, 221/4
Activity
Розничная торговля фармацевтическими товарами в специализированных магазинах, являющихся торговыми объектами, с торговой площадью менее 2000 кв.м

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

3/22
Tax arrears over 150 MCI (sole traders — 10 MCI)Review

Комитет государственных доходов · data as of 22.11.2026

Arrears on social health-insurance contributionsReview

Комитет государственных доходов · data as of 01.01.2026

The agency rarely updates this list. We check it every night, last on November 22, 2026.

Arrears on social contributionsReview

Комитет государственных доходов · data as of 01.01.2026

The agency rarely updates this list. We check it every night, last on November 22, 2026.

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "VET-APTEKA.LTD"
BIN
211140013912
Legal address
Алматы пр. РАЙЫМБЕКА, 221/4
VAT payer
No, deregistered 15.10.2024. Reason: absence by location
КАТО
751510000
РНН
600500662816
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 6 до 10 чел.

Has changed

Activities

47731 Розничная торговля фармацевтическими товарами в специализированных магазинах, являющихся торговыми объектами, с торговой площадью менее 2000 кв.м

1
47731primary

Розничная торговля фармацевтическими товарами в специализированных магазинах, являющихся торговыми объектами, с торговой площадью менее 2000 кв.м

Download

Contacts

Change history

Financials

Tax payments

6
0 ₸in 2025, −100% vs 2024
By year · ₸
  1. 2021, partial: 0 ₸
  2. 2022: 3.9M ₸
  3. 2023: 6.2M ₸
  4. 2024: 2.1M ₸
  5. 2025: 0 ₸
  6. 2026, partial: 0 ₸
  1. 2021, partial: 0 ₸
  2. 2022: 3.9M ₸
  3. 2023: 6.2M ₸
  4. 2024: 2.1M ₸
  5. 2025: 0 ₸
  6. 2026, partial: 0 ₸
Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

People & owners

Leadership

1
  • КТ

    Кохан Татьяна Игоревна

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Networks & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

Active legal entity ТОО "VET-APTEKA.LTD" (BIN 211140013912), Almaty. Registered in 2021, 5 years on the market. Main activity: retail trade. Enterprise category: small enterprise, 6 to 10 employees. No tax payments were received by the budget in 2025 (per the tax authority as of September 26, 2026). Automated screening found 3 risk indicators for «VET-APTEKA.LTD», the main one being tax arrears over 150 MCI (sole traders — 10 MCI). Date of the last change record: November 1, 2023 (change in headcount). Number of founders: 3. The registry names Кохан Татьяна Игоревна as director. Per the registry as of June 11, 2026.

Data sources and disclaimer

Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.